Sentences with phrase «stock less liabilities»
It looks like the Dresden mill alone is worth far more than the market cap of the stock less liabilities to the parent company.
https://longtermvalue.wordpress.com/ Not exact matches
«If you anticipate the kind of huge appreciation in your personal wealth that could come from an IPO or a company sale, the best thing you can do is transfer stock to your heirs before the sale, because it will be worth much less then, and that minimizes the tax liability,» explains Allan Landau, a partner with Boston law firm Sherburne, Powers & Needham.
Its wealth (sometimes referred to as «net worth») is the total stock of assets it has as a result of inheritance and saving, less any liabilities.
Valuation: Price - to - book ratio compares a stock's market value to the value of total assets less total liabilities (book value).
The initial public offering price is substantially higher than the pro forma net tangible book value per share of our common stock immediately following this offering based on the total value of our tangible assets less our total liabilities.
Heastie's most recent financial disclosure statement also showed modest investments worth less than $ 10,000 — a far cry from Silver's stock portfolio of up to $ 2.5 million — up to $ 50,000 in credit card debts and $ 20,000 in debt consolidation liabilities.
Price / book (or P / B) ratio is calculated by dividing the market price of a company's outstanding stock by its book value (total assets of a company less liabilities) and then adjusting for the number of shares outstanding.
We've been following AVGN (see earlier posts here and here) because it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and it has a specialist biotechnology activist fund Biotechnology Value Fund (BVF) pushing it to liquidate and return its cash to shareholders.
We've been following AVGN (see earlier posts here, here, here, here, here and here) because it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and specialist biotechnology activist fund BVF has been pushing it to liquidate and return its cash to shareholders.
We've been following AVGN (see earlier posts here, here and here) because it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and it has a specialist biotechnology activist fund Biotechnology Value Fund (BVF) pushing it to liquidate and return its cash to shareholders.
We posted about Avigen, Inc. (NASDAQ: AVGN) on December 1, 2008, noting that it was a rare opportunity because it was a net cash stock (i.e. it was trading at less than the value of its cash after deducting all liabilities).
The Net Current Asset Value (NCAV) calculates the value of a firm's cash, inventory, and receivables less all liabilities and preferred stock which is treated as debt.
Graham loved «net - nets ``, stocks trading substantially less than the current assets of the company minus all its liabilities.
We opened our position because AVGN was a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities), albeit a cash burning net cash stock, and BVF was pushing it to liquidate and return its cash to shareholders.
Based on speculation that Merck's liability could be as high as $ 50 billion, the stock tanked from $ 45 to $ 26 in less than two months in late 2004.
Second, I stick to stocks with low price - to - book - value ratios (P / B), because they offer investors a discount to the value of their assets less their liabilities.
Yet, had you focused exclusively on net nets (Graham's famous approach whereby one only buys stock in companies where the sum of current assets less all liabilities exceeds the market value), you would have cashed in 29.4 % annually in the same period.
My first, more limited, technique confines itself to the purchase of common stocks at less than their working - capital value, or net - current asset value, giving no weight to the plant and other fixed assets, and deducting all liabilities in full from the current assets.
But perhaps there is more uncertainty around the valuations of less well - capitalized firms than BRK, so buying back higher quality BRK stock is preferred to buying in the liabilities of companies of which Buffett has less knowledge.
We've been following AVGN (see archived posts here) because it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and specialist biotechnology investor Biotechnology Value Fund (BVF) has been pushing it to liquidate and return its cash to shareholders.
The net current assets investment selection criterion calls for the purchase of stocks which are priced at 66 % or less of a company's underlying current assets (cash, receivables and inventory) net of all liabilities and claims senior to a company's common stock (current liabilities, long - term debt, preferred stock, unfunded pension liabilities).
Berkshire was a classic «net net» — a stock trading for less than the value of its cash, receivables, and inventory less all liabilities.
We've been following AVGN (see archived posts here) because it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and specialist biotechnology investor BVF has been pushing it to liquidate and return its cash to shareholders.
We've been following AVGN (see archived posts here) because it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and specialist biotechnology activist fund BVF has been pushing it to liquidate and return its cash to shareholders.
We've been following AVGN (see archived posts here) for exactly the reason that Pollack identifies: it's a net cash stock (i.e. it's trading at less than the value of its cash after deducting all liabilities) and specialist biotechnology activist fund BVF has been pushing it to liquidate and return its cash to shareholders.